BeiGene
BeiGene is a life sciences biotechnology company.
BeiGene, founded in October, 2010 and headquartered in Beijing, is an anti-tumor drug developer. The founder is Wu Xiaobin. Listed on the HKEX on August 8, 2018, the company's major shareholders are Beigene, Ltd.. Rivals that have direct and indirect competition with BeiGene include Kintor, HitGen, Aprea Therapeutics, BridgeBio Pharma, etc.
Qiuzhen medical and tianguangshi have reached strategic cooperation to develop diagnostic kits and tumor drugs
Sinopharm new coronavirus vaccine approved
Another protein component special medical food was approved, and the total number of approved products increased to 57
Phase I project of Guangzhou Pharmaceutical production base of nuocheng Jianhua was completed
Research
Consumer Staples, Healthcare, TechnologyWIA2020 | Rising Tech Stars 2020: Global & China's 100
Research
Industrials, Financials, AutomotiveTech for Global, Globalization Footprints of the Established and the New
Research
Industrials, Financials, AutomotiveLow-Carbon Industry Expansion - Key Studies From Chinese Companies
BGI and Hanwei intelligent medical jointly launched mobile "two cancer" intelligent screening
Asc41, a candidate drug for NASH, was administered to overweight and obese subjects in phase IB clinical trial
Fosun medicine: the new crown vaccine has been included in the domestic phase II clinical, and no serious adverse report has been received
Cell and gene therapy cro / cdmo xuanming cells completed a round of financing, led by Huagai capital and juming venture capital
WIM2020: Insights on the Post-pandemic Outlook for the Healthcare Industry
The curtain came down on Dec 10 on the 'Healthtech Industry and COVID-19 Pandemic' Chapter at WIM 2020. Healthtech entrepreneurs and investors gathered to share insights on the outlook for the healthcare industry, covering topics like vaccination, AI healthcare, intelligent hardware, medical appliances and IVD.
Jan 07, 2021 02:10 PM
WIM2020: Uniting the World through Technology and Innovation
On December 9-12, EqualOcean held the World Innovators Meet (WIM) 2020. This year, the event's main topic was 'Technology and Innovation Connect the World.' WIM2020 gathered innovators from Asia, Africa, Europe and North America to share their knowledge and key achievements, promoting the concept of 'Tech for Equal.'
Dec 17, 2020 07:53 PM
Improving service quality and enabling industrial innovation!
Pfizer submitted to FDA for authorization of emergency use of new crown vaccine
The new crown vaccine developed by academician Chen Wei and kangxinuo biology can be stable for a long time from 2 to 8 degrees
Geli pharmaceutical: asc40 (tvb-2640) China has completed phase II NASH patients
Heyuan biological has completed a new round of financing of 450 million yuan, and car-t products with independent intellectual property rights have entered clinical phase II
Baiji Shenzhou: midterm analysis of the global phase III clinical trial for the treatment of non-small cell lung cancer reached the main end point
Hillhouse Will Inject USD 1 billion in BeiGene's Share Sale